Stephen David Prior

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Lucy Day, Attorney-in-Fact for Stephen David Prior
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen David Prior:

Company Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Chief Strategy Officer Common Stock 59,086 $59,795 $1.01 06 Jan 2026 Direct
AN2 Therapeutics, Inc. Chief Strategy Officer Stock Option (right to buy) 56,000 26 Feb 2025 Direct

Insider Reports Filed by Stephen David Prior

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANTX AN2 Therapeutics, Inc. 05 Jan 2026 2 -$6,507 4 Chief Strategy Officer 07 Jan 2026, 20:15
ANTX AN2 Therapeutics, Inc. 04 Nov 2025 1 -$872 4 Chief Strategy Officer 06 Nov 2025, 18:11
ANTX AN2 Therapeutics, Inc. 26 Feb 2025 2 $0 4 Chief Strategy Officer 28 Feb 2025, 16:19
ANTX AN2 Therapeutics, Inc. 03 Jan 2025 1 -$2,721 4 Chief Strategy Officer 07 Jan 2025, 19:57
ANTX AN2 Therapeutics, Inc. 04 Nov 2024 2 $0 4 Chief Strategy Officer 05 Nov 2024, 16:57
ANTX AN2 Therapeutics, Inc. 04 Nov 2024 0 $0 3 Chief Strategy Officer 05 Nov 2024, 16:49